Frontiers reaches 6.4 on Journal Impact Factors
Frontiers in Cardiovascular Medicine is a global, peer-reviewed Open Access medical journal providing unrestricted, online access to publications on diagnostic and therapeutic advances in cardiology and cardiovascular disease. Frontiers in Cardiovascular Medicine publishes peer-reviewed scientific investigations of the highest quality that are of relevance for the diagnosis, treatment, or pathogenesis of cardiovascular disease and related disorders with the goal to understand disease processes and to improve medical practice and patient care.
The specialty section Cardiovascular Imaging is devoted to publishing high quality articles and images relating to current and future clinical applications of non-invasive and invasive imaging. Relevant imaging modalities include echocardiography, CT, CMR, nuclear imaging, angiography, intravascular ultrasound, optical coherence tomography, computational modelling of the cardiovascular system, and molecular imaging with the potential for future clinical application.
Developments in cardiovascular imaging during the 20th and 21st centuries have been instrumental in transforming our understanding of cardiovascular pathophysiology, and in defining diagnostic and therapeutic approaches to disease. Future developments in technology are likely to more strongly unify pathophysiology, molecular medicine and cardiovascular imaging. A major aim of this speciality section is to provide a forum for interaction between clinicians, scientists, engineers and biologists with an interest in cardiovascular imaging. Our goal is to provide an efficient, unbiased and constructive assessment of all submitted manuscripts.
We therefore encourage submission of papers reporting basic and clinical imaging of cardiovascular diseases. Imaging of preclinical disease, imaging in relation to clinical outcome and imaging elucidating pathogenesis of disease, including animal studies.
With their manuscript, authors should submit a cover letter clearly stating what is novel about their work, and why it matters to patients now, or why it will change our understanding of pathogenesis or our future approaches to cardiovascular imaging.
The Editors of Frontiers in Cardiovascular Medicine encourage submission of Original Research Articles (clinical or preclinical), Reviews, Mini Reviews and Case Reports. Original research articles include manuscripts reporting results from clinical investigations, including Phase I-III trials and population studies. Reports from experimental studies from related areas such as physiology, pathophysiology, cellular and molecular biology, genetics, or pharmacology may be considered as as long as they relate to new understandings of pathogenic mechanisms or novel therapeutic approaches relevant to human disease. Articles related to medical education or the future development of medicine may also be considered.
Indexed in: PubMed, PubMed Central, Google Scholar, DOAJ, CrossRef, Semantic Scholar, Ulrich's Periodicals Directory, CLOCKSS
PMCID: all published articles receive a PMCID
Cardiovascular Imaging welcomes submissions of the following article types: Case Report, Clinical Study Protocol, Correction, Editorial, General Commentary, Hypothesis and Theory, Mini Review, Opinion, Original Research, Perspective, Review and Systematic Review.
All manuscripts must be submitted directly to the section Cardiovascular Imaging, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Articles published in the section Cardiovascular Imaging will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in all Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Cardiovascular Medicine.